Literature DB >> 1328123

New hepatocellular carcinoma cell line SUHC-1 established from a patient with hepatitis C virus RNA in serum.

K Yoshizawa1, K Kiyosawa, S Usuda, K Yabu, Y Nakatsuji, S Yamada, K Furuta, E Tanaka, T Sodeyama, S Furuta.   

Abstract

A new human hepatocellular carcinoma cell (HCC) line, designated SUHC-1, was derived from a Japanese patient with hepatocellular carcinoma having antibody to hepatitis C virus (HCV) and HCV-RNA in his serum, and established in tissue culture. This cell line exhibited typical epithelial cell morphology in culture as observed by phase-contrast and electron microscopy. The SUHC-1 cells produced albumin and alpha 2-macroglobulin. Chromosomal analysis showed several rearrangements at short and long arms of chromosome 1, 17 and 20 (1p-, 1q-, i(1q), i(17q) and 20q+) with a modal number of 91. HCV-RNA was not detected in the supernatant of SUHC-1 cells by nested polymerase chain reaction assay or in the SUHC-1 cells by the in situ hybridization method. We concluded that complete HCV does not exist in the SUHC-1 cell line. The SUHC-1 cell line is the first line of HCC to have been derived from a patient with persistent HCV infection, and may provide a suitable model for studies of hepatocarcinogenesis related to HCV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328123      PMCID: PMC5918961          DOI: 10.1111/j.1349-7006.1992.tb01993.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellular carcinoma hepatitis B virus hepatitis C virus polymerase chain reaction alpha‐fetoprotein carcinoembryonic antigen
  25 in total

1.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

2.  Lack of detectable reverse transcriptase activity in human and chimpanzee sera with a high infectivity for non-A, non-B hepatitis.

Authors:  Y Itoh; S Iwakiri; K Kitajima; T Gotanda; M Miyaki; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

3.  Characteristics of a cell line (Tong/HCC) established from a human hepatocellular carcinoma.

Authors:  D Stevenson; J H Lin; M J Tong; G J Marshall
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

4.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

5.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

6.  Hepatitis B virus transcripts in a human hepatoma cell line, Hep 3B.

Authors:  T S Su; L H Lin; C K Chou; C M Chang; L P Ting; C P Hu; S H Han
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

7.  Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line.

Authors:  P Bagnarelli; G Devescovi; A Manzin; I Bearzi; P Bonazzi; G Carloni; M Clementi
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

8.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

9.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.